Adverse effects of neutrophils on the lung.
Studies of both emphysema and adult respiratory distress syndrome (ARDS) support the premise that lung injury is due to unregulated host defense mechanisms. A major mediator of host defense and injury is the neutrophil, which is relatively incapable of regulating its own function. Accordingly, defects in regulatory mechanisms allow neutrophils to damage the lungs. Emphysema serves as a prime example of this link between host defense and injury. Hereditary emphysema is caused by a deficiency in alpha 1-antitrypsin (alpha 1-AT), a protease inhibitor. The decreased levels of this enzyme in affected individuals result in inadequate protection against neutrophil elastase and other proteolytic enzymes, leading to lung damage. Patients with acquired emphysema, associated with cigarette smoking, have normal levels of alpha 1-AT in their lungs. However, the alpha 1-AT in these patients has a reduced ability to associate with and inhibit the action of neutrophil elastase. Thus, both types of emphysema involve an alteration in the balance between proteases and antiproteases. The lung damage observed in patients with ARDS also appears to involve neutrophils, but in this case elastase may not be the culprit. In these patients, neutrophil elastase appears to be inactivated by high levels of alpha 1-AT, thus preventing excess protease action. It is hoped that a more complete understanding of the mechanisms involved in host defense and injury will enable the development of specific therapeutic interventions, such as the alpha 1-AT replacement therapy that is being used to treat patients with hereditary emphysema.
Gadek
J E
JE
Department of Pulmonary and Critical Care Medicine, School of Medicine, Ohio State University, Columbus 43210.
D004646:Emphysema / Q000201:enzymology / Q000235:genetics / Q000276:immunology*; D010450:Endopeptidases / Q000096:biosynthesis / Q000276:immunology; D005609:Free Radicals / Q000276:immunology; D006801:Humans; D019272:Leukocyte Elastase; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism; D016877:Oxidants / Q000009:adverse effects; D010196:Pancreatic Elastase / Q000276:immunology; D009195:Peroxidase / Q000276:immunology; D011480:Protease Inhibitors / Q000276:immunology; D012128:Respiratory Distress Syndrome / Q000201:enzymology / Q000209:etiology / Q000276:immunology*; D012907:Smoking / Q000009:adverse effects; D000515:alpha 1-Antitrypsin / Q000276:immunology; D019896:alpha 1-Antitrypsin Deficiency
D005609:Free Radicals; D016877:Oxidants; D011480:Protease Inhibitors; D000515:alpha 1-Antitrypsin; D009195:Peroxidase; D010450:Endopeptidases; D010196:Pancreatic Elastase; D019272:Leukocyte Elastase